adr_usa_0457|ADXN|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|average_shares_outs_diluted|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|price_next_month|
adr_usa_0457|ADXN|Long Name|Addex Therapeutics Ltd Total Current Assets (Quarterly) (USD)|Addex Therapeutics Ltd Cash and Short Term Investments (Quarterly) (USD)|Addex Therapeutics Ltd Inventories (Quarterly) (USD)|Addex Therapeutics Ltd Net PP&E (Quarterly) (USD)|Addex Therapeutics Ltd Goodwill and Intangibles (Quarterly) (USD)|Addex Therapeutics Ltd Total Liabilities (Quarterly) (USD)|Addex Therapeutics Ltd Total Current Liabilities (Quarterly) (USD)|Addex Therapeutics Ltd Total Long Term Liabilities (Quarterly) (USD)|Addex Therapeutics Ltd Total Deposits (Quarterly) (USD)|Addex Therapeutics Ltd Book Value (Quarterly) (USD)|Addex Therapeutics Ltd Retained Earnings (Quarterly) (USD)|Addex Therapeutics Ltd Treasury Stock (Quarterly) (USD)|Addex Therapeutics Ltd EV to Revenues|Addex Therapeutics Ltd EV to Earnings|Addex Therapeutics Ltd EV to Free Cash Flow|Addex Therapeutics Ltd EV to Assets (Quarterly)|Addex Therapeutics Ltd PS Ratio|Addex Therapeutics Ltd PE Ratio|Addex Therapeutics Ltd Price to Book Value|Addex Therapeutics Ltd PEG Ratio|Addex Therapeutics Ltd Debt to Equity Ratio|Addex Therapeutics Ltd Dividend Yield|Addex Therapeutics Ltd Shareholder Yield (TTM)|Addex Therapeutics Ltd Percent of Shares Outstanding Short|Addex Therapeutics Ltd Average Diluted Shares Outstanding (Quarterly)|Addex Therapeutics Ltd EPS Diluted (Quarterly) (USD)|Addex Therapeutics Ltd Dividend Per Share (Quarterly) (USD)|Addex Therapeutics Ltd Revenue (Quarterly) (USD)|Addex Therapeutics Ltd Gross Profit (Quarterly) (USD)|Addex Therapeutics Ltd SG&A Expense (Quarterly) (USD)|Addex Therapeutics Ltd Pre-Tax Income (Quarterly) (USD)|Addex Therapeutics Ltd Net Income (Quarterly) (USD)|Addex Therapeutics Ltd Net Interest Income (Quarterly) (USD)|Addex Therapeutics Ltd Price (USD)|Addex Therapeutics Ltd Total Return Price (USD)|Addex Therapeutics Ltd Enterprise Value (USD)||
adr_usa_0457|ADXN|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric||
adr_usa_0457|ADXN|200912|75.7064|73.931||9.2395|0.1753|10.5957|10.516|0.0797||74.9167|-158.6422|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201006|55.2937|52.583||7.44|0.1157|7.1596|6.9019|0.2577||56.0645|-168.4039|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201012|71.1363|68.2504||7.1336|0.0898|10.5587|9.9249|0.6338||68.9103|-211.7444|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201106|63.6818|60.2766||6.4927|0.0664|11.6757|10.7333|0.9424||59.7769|-255.3073|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201112|40.4739|38.3447||4.215|0.0343|12.386|9.2797|3.1064||33.9866|-245.5351|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201206|23.2338|20.9633||2.7993|0.128|8.9764|8.2171|0.7593||20.1744|-252.5812|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201212|18.6444|16.7122||2.2889|0.1069|8.1279|5.1004|3.0275||15.6814|-282.1216|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201306|6.6076|4.7384||0.5445|0.0788|6.9469|6.9469|0||3.0504|-287.7771|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201312|4.3957|3.2828||0.2023|0.0593|3.2155|2.6629|0.5526||3.4097|-306.5043|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201406|2.7835|2.3492||0.0839|0.0361|2.6489|2.0348|0.614||2.3005|-306.2873|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201412|2.1632|2.002||0.0452|0.0134|1.6722|1.526|0.1462||2.3722|-276.8817|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201506|4.1061|3.8642||0.0229|0.0002|1.2567|1.0553|0.2014||2.9536|-298.6403|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201512|2.8153|2.6644||0.0322|0|1.2398|1.0419|0.198||1.6837|-281.2446|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201606|2.617|2.3014||0.0312|0|1.4503|1.058|0.3923||1.2048|-285.2622|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201612|1.6299|1.3919||0.017||1.4391|1.2283|0.2107||0.2148|-276.289|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201706|4.014|3.7407||0.0048||1.5362|1.2982|0.238||2.4901|-296.0848|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201712|3.1346|2.6594||0.0028||1.7664|1.5161|0.2504||1.3782|-291.9875|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201806|44.9623|43.6737||0.0041||2.6028|2.3588|0.244||42.3707|-282.7164|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201812|42.8123|42.3325||0.009||3.0199|2.3705|0.6494||39.8567|-290.5579|||||||||||||||||||||||||||
adr_usa_0457|ADXN|201903||||||||||||||||||||||||||||0.7034||1.5045|-3.0518|-3.0518|-0.0408|||||
adr_usa_0457|ADXN|201906|38.3842|37.6255||0.429||5.831|4.5093|1.3217||33.0379|-300.5658||||||||||0|||||||0.518||1.4746|-4.4873|-4.4873|-0.0332|||||
adr_usa_0457|ADXN||||||||||||||||||||||||||||||||||||||14.5|2020-01-29/dividend_yield|0|2020-01-30/dividend_yield|0|2020-01-31/dividend_yield|0|2020-02-03/dividend_yield|0|2020-02-04/dividend_yield|0|2020-02-05/dividend_yield|0|2020-02-06/dividend_yield|0|2020-02-07/dividend_yield|0|2020-02-10/dividend_yield|0|2020-02-11/dividend_yield|0|2020-02-12/dividend_yield|0|2020-02-13/dividend_yield|0|2020-02-14/dividend_yield|0|2020-02-18/dividend_yield|0|2020-02-19/dividend_yield|0|2020-02-20/dividend_yield|0|2020-02-21/dividend_yield|0|2020-02-24/dividend_yield|0|2020-02-25/dividend_yield|0|2020-02-26/dividend_yield|0|2020-02-27/dividend_yield|0|2020-02-28/dividend_yield|0|2020-01-29/price|14.5|2020-01-30/price|14.5|2020-01-31/price|13.5|2020-02-03/price|13.5|2020-02-04/price|13.5|2020-02-05/price|13.5|2020-02-06/price|13.5|2020-02-07/price|13.5|2020-02-10/price|13.5|2020-02-11/price|13.5|2020-02-12/price|11.3|2020-02-13/price|11.3|2020-02-14/price|11.3|2020-02-18/price|11.3|2020-02-19/price|11.3|2020-02-20/price|11.3|2020-02-21/price|11.3|2020-02-24/price|11.3|2020-02-25/price|11.3|2020-02-26/price|11.3|2020-02-27/price|11.3|2020-02-28/price|11.3|2020-01-29/total_return_price|14.5|2020-01-30/total_return_price|14.5|2020-01-31/total_return_price|13.5|2020-02-03/total_return_price|13.5|2020-02-04/total_return_price|13.5|2020-02-05/total_return_price|13.5|2020-02-06/total_return_price|13.5|2020-02-07/total_return_price|13.5|2020-02-10/total_return_price|13.5|2020-02-11/total_return_price|13.5|2020-02-12/total_return_price|11.3|2020-02-13/total_return_price|11.3|2020-02-14/total_return_price|11.3|2020-02-18/total_return_price|11.3|2020-02-19/total_return_price|11.3|2020-02-20/total_return_price|11.3|2020-02-21/total_return_price|11.3|2020-02-24/total_return_price|11.3|2020-02-25/total_return_price|11.3|2020-02-26/total_return_price|11.3|2020-02-27/total_return_price|11.3|2020-02-28/total_return_price|11.3
adr_usa_0457|ADXN|202003|29.5015|28.2664||0.503||7.3894|5.9013|1.4881||22.6869|-317.8464||||||||||0|0||||||0.9343||1.5811|-4.45|-4.45|-0.0069|6.6|6.6|||
adr_usa_0457|ADXN|202006|23.8581|21.7903||0.4066||4.5692|2.9533|1.6158||19.7676|-324.1151||||||||||0|||||||0.8932||1.647|-3.2319|-3.2319|-0.0076|||||
adr_usa_0457|ADXN||||||||||||||||||||||||||||||||||||||12.6808|2020-10-07/dividend_yield|0|2020-10-08/dividend_yield|0|2020-10-09/dividend_yield|0|2020-10-12/dividend_yield|0|2020-10-13/dividend_yield|0|2020-10-14/dividend_yield|0|2020-10-15/dividend_yield|0|2020-10-16/dividend_yield|0|2020-10-19/dividend_yield|0|2020-10-20/dividend_yield|0|2020-10-21/dividend_yield|0|2020-10-22/dividend_yield|0|2020-10-07/price|12.6808|2020-10-08/price|12.6808|2020-10-09/price|12.6808|2020-10-12/price|12.6808|2020-10-13/price|11.7701|2020-10-14/price|12.2|2020-10-15/price|12.2|2020-10-16/price|12.2|2020-10-19/price|12.455|2020-10-20/price|12.455|2020-10-21/price|12.455|2020-10-22/price|12.455|2020-10-07/total_return_price|12.6808|2020-10-08/total_return_price|12.6808|2020-10-09/total_return_price|12.6808|2020-10-12/total_return_price|12.6808|2020-10-13/total_return_price|11.7701|2020-10-14/total_return_price|12.2|2020-10-15/total_return_price|12.2|2020-10-16/total_return_price|12.2|2020-10-19/total_return_price|12.455|2020-10-20/total_return_price|12.455|2020-10-21/total_return_price|12.455|2020-10-22/total_return_price|12.455